A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine

Overview of attention for article published in Science Translational Medicine, May 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 9 X users
bluesky: 3 Bluesky users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

New B meningococcus vaccine shows promise in early-stage trial

M 3 Medical, 16 May 2025

The outcome of a trial published inScience Translational Medicine, shows encouraging results for a new vaccine targeting group…

New B meningococcus vaccine shows promise in early-stage trial

Today Headline, 16 May 2025

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group…

New B meningococcus vaccine shows promise in early-stage trial

MedicalXpress, 16 May 2025

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.